Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Threatens to expand strikes
Is the news racist?
Shutdown could impact travel
'Scandal does not define me'
Sexually assaulted patients?
Clinton taunts Putin
Judge strikes down drag ban
Louisiana state of emergency
Flight attendant found dead
Visa-free travel for Israelis
‘She looked amazing’
Drug-test welfare recipients?
Postpones rest of '23 shows
Recall nearly 3.4M vehicles
VA church shooting thwarted
Tech CEO murder suspect
Busch sells NASCAR team
Blasts X over disinformation
Released in error, captured
RU accuses UKR allies
Ozempic prescriptions surge
Slams judge’s fraud ruling
‘America is going full Joker’
Empty frames artwork appeal
Birthday celebration moved
Ireland's biggest drug haul
DC surpasses 200 homicides
Menendez pleads not guilty
Ryder Cup All-Star match
Huge North Sea oilfield OK'd
DE bans neo-Nazi group
Ex-Karabakh leader detained
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
147,000 results
WSB Radio
20m
FDA advisers vote against experimental ALS treatment pushed by patients
Federal health advisers have voted overwhelmingly against recommending approval of an experimental treatment for Lou Gehrig's ...
5hon MSN
Health Headlines: FDA approves Alzheimer treatment
CLEVELAND, Ohio (Ivanhoe Newswire) – More than six million Americans are living with Alzheimer’s disease, it slowly steals ...
ENDPOINTS NEWS
35m
Ad­comm rec­om­mends FDA re­ject Brain­Stor­m's ALS drug af­ter com­pa­ny filed over protest
A panel of independent experts on Wednesday recommended the FDA reject an experimental ALS drug developed by the biotech BrainStorm Cell Therapeutics, marking another defeat for the long embattled ...
6don MSN
Medical Moment: FDA approves first-ever drug to slow Alzheimer’s
There is no cure yet, but now, a newly FDA-approved drug is helping to slow its progression before it’s too late.
The Bismarck Tribune
1d
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
The Food and Drug Administration is considering a much-debated new treatment for Lou Gehrig’s disease, a deadly neurological ...
朝日新聞社8d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 JST Share Tweet list Print This image provided by Eisai in January 2023 shows vials and packaging for ...
Seeking Alpha19d
Vigil Neuroscience study for Alzheimer's drug to proceed with FDA restrictions
Vigil Neuroscience (NASDAQ:VIGL) said the FDA is allowing a Phase 1 clinical trial for its Alzheimer’s drug candidate VG-3927 to proceed with a partial clinical hold related to the maximum drug ...
1don MSN
After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Forbes16d
What To Know About The Alzheimer’s Drug Leqembi
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.
Washington Examiner26d
FDA needs to let go of its risk-averse regulatory model
The FDA also gave full approval to a drug called Leqembi, which slowed Alzheimer’s patients’ functional and cognitive decline by 27% over 18 months, according to trial data.
The Financial Times24d
Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant
We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...
pharmaphorum3d
Celgene’s multiple myeloma orphan drug gets FDA approval
Celgene’s multiple myeloma treatment has been approved by the US FDA. Pomalyst has been approved to treat patients with this form of blood cancer whose disease progressed after being treated ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices